An in vivo study of NOX1416 for the treatment of burn wounds consisting of full thickness burns in combination with infection
Active Project Grant Awarded
- Award ID
- HT9425261E376
- Recipient
-
Noxy Health Products Inc. UEI S75SVTCAPL41
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $1,508,980
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date 14% complete
- Place of performance
- Anaconda, MT 59711, USA
Award details come from USAspending.gov.
About this award
The Defense Health Agency awarded Noxy Health Products Inc. $1,508,980 on July 15, 2026, under the Military Medical Research and Development program (CFDA 12.420) to conduct an in vivo study of NOX1416 for the treatment of full-thickness burn wounds in combination with infection. The research will be performed in Anaconda, Montana, with a period of performance extending through July 14, 2028. This project grant supports the Defense Health Agency's mission to transform health care for Service Members and the American public through innovative biomedical research and to investigate medical solutions for battlefield conditions.
Quick answers
Who received award HT9425261E376?
HT9425261E376 was awarded to Noxy Health Products Inc. by Defense Health Agency (Department of Defense) on July 15, 2026.
How much is award HT9425261E376 worth?
$1,508,980 has been obligated on HT9425261E376.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award